April 2021 FDA Recall Delflex by Fresenius Medical Care, North America
D-0389-2021 - Labeling; Label Mix-up; 4.25% DEXTROSE bag was found inside a 1.5% DEXTROSE box.

This Class II drug recall was voluntarily initiated by Fresenius Medical Care, North America on April 14, 2021 for the product Delflex. The FDA reported the reason for recall as labeling; label mix-up; 4.25% dextrose bag was found inside a 1.5% dextrose box.. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0389-2021

Reason for Recall
Labeling; Label Mix-up; 4.25% DEXTROSE bag was found inside a 1.5% DEXTROSE box.
Initiated
04-14-2021
Reported
05-26-2021
Quantity
709 cases

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Fresenius Medical Care, North America
Delflex Peritoneal Dialysis Solution with 1.5% Dextrose, LM/LC, packaged in a case containing 2 x 6 Liter bags, Rx only, NDC 49230-206-60, Fresenius Medical Care North America, Waltham, MA 02451

Batch or Lot Expiration Information

Lot# 20SU03019, Exp 6/2022